Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

This study is testing a shorter treatment method for prostate cancer using proton therapy (PT), which is very precise and may cause fewer side effects compared to traditional radiation. However, it is expensive and not easily accessible for many patients. To make it more affordable and accessible, this study is testing whether 2 fractions of stereotactic body proton therapy (SBPT) can be as safe and effective as the standard 5 sessions.

Trial Details

NCT ID
NCT07130682
Phase
NA
Sponsor
Hong Kong Sanatorium & Hospital
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Pencil Beam Proton Therapy Treatment Machine
Locations (sample)
  • Hong Kong, Hong Kong|22.27832,114.17469

Key Eligibility Criteria

  • Men aged \< 18 years with histologically confirmed low- or intermediate-risk prostate cancer per NCCN guidelines
  • Eastern Cooperative Oncology Group (ECOG) performance status \<2
  • Ability to undergo magnetic resonance imaging (MRI) simulation scans without absolute contraindications, such as cardiac implantable electronic dev…
  • Ability to complete the Expanded Prostate Cancer Index Composite (EPIC) questionnaire

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →